AcquiredStartups
Acquirer · Corporate

Dechra

1Exits trackedUndisclosedDisclosed value—Median price0Acquihires
Image: Dechra (press release)
Healthtech & bio · San Diego

Dechra buys Gallant to add off-the-shelf stem-cell therapies for pets

The EQT-owned veterinary drugmaker closed the deal a week after agreeing it, taking on a San Diego biotech whose first product is expected as early as 2027.

PriceUndisclosedRaisedn/aLast stageSeries BBuyer typeCorporate
Latest in DechraMore stories here soon.